Interstitial Cystitis market The Interstitial Cystitis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)....
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - MOUNTAINTODAY.IN - A La Une - 11/Jul 15:28
Leiomyosarcoma Pipeline 2024 | Merck, Advenchen Laboratories, Trillium Therapeutics, PTC Therapeutics, PharmaMar, Philogen, EMD Serono, Incyte Corporation, Clovis Oncology Inc.
DelveInsight’s, “Leiomyosarcoma Pipeline Insight 2024” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Leiomyosarcoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also
Articles similaires
Interstitial Cystitis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest EMA, PDMA, FDA Approvals by DelveInsight | Merck & Co, Teva Pharmaceutical Industries, Integrative Therapeutics
mountaintoday.in - 04/Sep 07:57
Interstitial Cystitis market The Interstitial Cystitis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)....
Iron Deficiency Anemia Market Analysis 2034 | Iron Deficiency Anemia Therapies, Clinical trials, Iron Deficiency Anemia prevalence, Treatment Algorithms | Akebia Therapeutics, Shield Therapeutics
mountaintoday.in - 04/Sep 08:17
Iron Deficiency Anemia Market As per DelveInsight, the Iron Deficiency Anemia Market is anticipated to grow immensely in the coming years owing to the...
Iron Deficiency Anemia Market Analysis 2034 | Iron Deficiency Anemia Therapies, Clinical trials, Iron Deficiency Anemia prevalence, Treatment Algorithms | Akebia Therapeutics, Shield Therapeutics
mountaintoday.in - 04/Sep 08:17
Iron Deficiency Anemia Market As per DelveInsight, the Iron Deficiency Anemia Market is anticipated to grow immensely in the coming years owing to the...
Xencor Stock Gains 23% on Encouraging Pipeline Advancements
zacks.com - 10/Sep 16:22
XNCR moves four new XmAb drug development programs for autoimmune diseases. It also provided favorable updates for two of its oncology drug...
Bayer, NextRNA to Develop Therapeutics Targeting Oncology
zacks.com - 29/Aug 13:18
BAYRY collaborates with NextRNA Therapeutics to develop small molecule therapeutics targeting lncRNAs in oncology.
Cumulus Oncology and leadXpro’s Collaboration on GPR68-Targeting Cancer Therapeutics
globallegalchronicle.com - 03/Sep 00:00
Taylor Wessing advised Cumulus Oncology Cumulus Oncology on its exclusive GPR68 licence and development collaboration with leadXpro. Cumulus Oncology...
PTC Inc. (PTC) Up 0.7% Since Last Earnings Report: Can It Continue?
zacks.com - 30/Aug 15:31
PTC Inc. (PTC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Deucrictibant clinical, real-World, nonclinical, and discovery data to be presented at the Bradykinin Symposium
haei.org - 28/Aug 17:26
Deucrictibant clinical, real-World, nonclinical, and discovery data to be presented at the Bradykinin Symposium Pharvaris announced the acceptance of...
Incyte (INCY) Up 0.9% Since Last Earnings Report: Can It Continue?
zacks.com - 29/Aug 15:31
Incyte (INCY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Les derniers communiqués
-
Aucun élément